MJBizDaily's recent commentary argues that genetics are the cannabis sector's most valuable, long‑lived resource. For breeders, seed banks, producers and buyers the piece is a prompt to move beyond short‑term commercial thinking: preserve provenance, manage risk from regulation and consolidation, and invest in the record‑keeping and legal tools that keep genetics usable and marketable.

MJBizDaily has flagged an emerging risk: a federal-level ban on hemp could seriously disrupt cannabis seed banks, breeder collections and the supply of established commercial genetics. This analysis explains the practical pathways by which legal change would matter to breeders, seedbank operators, distributors and research programmes - and what professionals should be watching and doing now.

MJBizDaily has highlighted a simple proposition: genetics are the cannabis industry’s most valuable asset. For breeders, seedbanks, producers and distributors that claim to sell consistency, potency or therapeutic value, that statement should change how contracts, quality assurance and corporate strategy are organised.